Published in P T on July 01, 2017
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med (1991) 16.19
Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med (2003) 13.25
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med (2004) 12.52
Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med (2014) 11.77
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med (2004) 11.44
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet (1999) 11.26
The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med (1997) 10.68
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet (1999) 10.07
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med (1987) 8.77
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet (2010) 8.17
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med (1993) 7.19
Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med (2001) 7.05
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med (1986) 6.58
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet (2009) 5.23
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 5.03
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation (1991) 4.65
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med (2004) 3.24
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J (1975) 2.71
Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol (1993) 2.49
Aldosterone in congestive heart failure. N Engl J Med (2001) 2.46
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE). Circulation (2002) 2.20
Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. J Card Fail (1999) 1.96
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study. J Am Coll Cardiol (2012) 1.94
Thiazide-sensitive sodium chloride cotransport in early distal tubule. Am J Physiol (1987) 1.82
Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension (1998) 1.46
Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol (1981) 1.26
Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project. J Am Coll Cardiol (2013) 1.21
Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol (2010) 1.15
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc Ther (2010) 1.12
Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension (1994) 0.91
Effect of bumetanide and furosemide on the thick ascending limb of Henle's loop of rabbits and rats perfused in vitro. Eur J Pharmacol (1977) 0.87
Balancing diuretic therapy in heart failure: loop diuretics, thiazides, and aldosterone antagonists. Congest Heart Fail (2002) 0.81
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood (2012) 1.85
Physician activities during time out of the examination room. Ann Fam Med (2005) 1.68
Sustainability of market-based community distribution of Sprinkles in western Kenya. Matern Child Nutr (2013) 1.05
Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Blood (2006) 0.95
Herpes zoster meningitis with multidermatomal rash in an immunocompetent patient. Am J Emerg Med (2013) 0.90
Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia. Leuk Lymphoma (2012) 0.90
Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency. Am J Hematol (2004) 0.84
Diversity and disparity: GIS and small-area analysis in six Chicago neighborhoods. J Med Syst (2004) 0.83
Paget-Schroetter syndrome. J Assoc Physicians India (2007) 0.83
Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia. Pediatr Blood Cancer (2013) 0.79
Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group. Pediatr Blood Cancer (2010) 0.79
Phenothiazinium-fluoroquinolone drug conjugates. Int J Antimicrob Agents (2010) 0.76
The utility of routine surveillance blood cultures in asymptomatic hematopoietic stem cell transplant patients. J Pediatr Hematol Oncol (2010) 0.75
Targeting Interleukin-5 in Patients With Severe Eosinophilic Asthma: A Clinical Review. P T (2017) 0.75
A 3-year-old boy with ataxia. Pediatr Emerg Care (2015) 0.75
An 11-year-old boy with cough. Clin Pediatr (Phila) (2013) 0.75
HIV testing practices and attitudes on prevention efforts in six diverse Chicago communities. J Community Health (2009) 0.75
Fibrin tissue adhesive and autologous concha cartilage for reconstruction of the posterior-superior canal wall of the chinchilla middle ear. Otol Neurotol (2004) 0.75